Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma Following Local Ablation
To evaluate the efficacy and safety of Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma following Local Ablation
Hepatocarcinoma
Progression-free survival (PFS), PFS was defined as the duration of time from start of treatment to time of disease progression., 96 weeks
Recurrence-Free Survival (RFS), RFS was defined as the duration of time from start of treatment to time of disease recurrence ., 96 weeks|Time to recurrence (TTR), TTR was defined as the time from shart of treatment to disease recurrence., Time from baseline to relapse (up to 96 weeks)|Overall Survival (OS), OS was defined as the time from start to death from any cause or last patient last visit., Time from baseline to death (up to 96 weeks)|Change From Baseline in Quality of Life (QOL), Quality of Life (QOL) were measured using supplemental quality of life questions. Item score range（12 items）: 1 (worst symptom) to 5 (no symptom). Change: score at 96 weeks minus score at baseline., 24, 48, 72, 96 weeks|Incidence rate of Adverse events (AE), An AE was any untoward medical occurrence in a participant who received study drug without regard to possibility of causal relationship., 96 weeks|severity of Adverse events (AE), An SAE was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged inpatient hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability/incapacity; congenital anomaly., 96 weeks
A multicenter, prospective cohort study investigating Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma following Local Ablation，to evaluate the efficacy and safety